Paper Review Records
All Paper Review Records
28 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
33
days
Practical Transfusion Medicine7th Edition Edited by Michael F.Murphy, Nancy M.Dunbar and Erica M.Wood, Wiley. 2026. ISBN‐10: 1394291965
Authors
Sue Pavord; Julie StavesShow moreShow less
Affiliations
1. Department of Haematology Oxford University Hospitals NHS Foundation Trust Oxford UKShow moreShow less
73
days
Complex karyotype and non‐ BTK driver mutations associated with BTK inhibitor resistance in chronic lymphocytic leukaemia
Authors
Kiyomi Mashima; Stacey M. Fernandes; Mariia Mikhaleva; Roberta Santos Azevedo; Stephen Martindale; Binu Kandathilparambil Sasi; Saurabh Yadav; Uday Aditya Sarkar; Rayan Fardoun; Xinhao Sun; Colin McNulty; Ava M. Kominski; Paige R. Fitzgerald; Ava Bidgoli; Paulina Predko; Samantha Shupe; John‐Hanson Machado; Aishath Naeem; Inhye E. Ahn; Matthew S. Davids; Jennifer R. BrownShow moreShow less
Affiliations
1. Department of Medical Oncology, CLL Center Dana‐Farber Cancer Institute Boston Massachusetts USA; 2. Department of Medicine Harvard Medical School Boston Massachusetts USAShow moreShow less
128
days
CD20 antigen loss post‐venetoclax/anti‐ CD20 therapy in chronic lymphocytic leukaemia: Frequency, characteristics and potential therapeutic implications
Authors
Tamasine Stewart; Sean McKeague; Divya Somasekharannair; Lei‐Shong Lau; Ashley Whitechurch; Joshua Casan; Neil Came; Kylie Baldwin; Vuong Nguyen; Ing Soo Tiong; Sean Harrop; Mary Ann Anderson; John F. Seymour; David Westerman; Philip A. Thompson; Kah Lok ChanShow moreShow less
Affiliations
1. Department of Pathology Peter MacCallum Cancer Centre Melbourne Victoria Australia; 2. Department of Clinical Haematology Peter MacCallum Cancer Centre and Royal Melbourne Hospital Melbourne Victoria Australia; 3. Department of Haematology Royal Brisbane and Women's Hospital Brisbane Queensland Australia; 4. Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne Victoria Australia; 5. School of Nursing and Midwifery La Trobe University Melbourne Victoria AustraliaShow moreShow less
135
days
Spatial and transcriptomic analyses reveal the adverse prognostic impact of regulatory T cells in follicular lymphoma treated with rituximab–lenalidomide
Authors
Camille Laurent; Marie Tosolini; Arnaud Guille; Bruno Tesson; Nathalie Van‐Acker; François‐Xavier Frenois; Andrea Belin‐Artola; Bastien Lesne; Pierre Brousset; BIDIFLY Consortium; Franck Morschhauser; Luc XerriShow moreShow less
Affiliations
1. Laboratoire d'Excellence TOUCAN, Centre de Recherches en Cancérologie de Toulouse INSERM U1037, Institut Universitaire Cancer‐Oncopole, CHU Toulouse Toulouse France; 2. Institut Paoli‐Calmettes, CRCM and Aix‐Marseille University Marseille France; 3. LYSARC Pierre Bénite France; 4. Hopital Claude Huriez Lille FranceShow moreShow less
175
days
A real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study
Authors
Victor Tellez; Anirvin Bommaraju; Jamie Cheung; Regina Swift; Jonathan Moore; Pierre Sayad; Frank Pezzullo; Aaron Gette; Alex Wright; Jon Hall; Randall Noval; Blake Morrison; James R. BerensonShow moreShow less
Affiliations
1. Berenson Cancer Center West Hollywood California USA; 2. Institute for Myeloma & Bone Cancer Research West Hollywood California USA; 3. mQOL San Jose California USAShow moreShow less
166
days
Temporal trends in infectious risk among multiple myeloma patients treated with daratumumab: A meta‐analysis
Authors
Alissa Visram; Hira Mian; James Lee; Aaron Jones; Gregory R. Pond; Doris Hansen; Surbhi Sidana; Luciano J. CostaShow moreShow less
Affiliations
1. Juravinski Cancer Centre Hamilton Health Sciences Hamilton Ontario Canada; 2. Department of Oncology, McMaster University Hamilton Ontario Canada; 3. ICES McMaster University Hamilton Ontario Canada; 4. Department of Health Research Methods, Evidence, and Impact McMaster University Hamilton Ontario Canada; 5. H. Lee Moffitt Cancer Centre & Research Institute Tampa Florida USA; 6. Division of Blood and Marrow Transplantation and Cellular Therapy Stanford University Stanford California USA; 7. Division of Hematology and Oncology, Department of Medicine University of Alabama at Birmingham Birmingham Alabama USAShow moreShow less
FAQ
How long does BRITISH JOURNAL OF HAEMATOLOGY take to review a manuscript?
As of 2026-11-17, CrushSCI has 28 complete review records for BRITISH JOURNAL OF HAEMATOLOGY. The fastest paper went from submission to acceptance in 7 days (The speed of sequencing: Rapid molecular testing in acute myeloid leukaemia, received 2026-10-06, accepted 2026-10-13); the slowest took 225 days. The average is 106.4 days and the median is 91.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
